MYC and neoplasm: In this context we documented previously that the clinically available highly specific PI3K inhibitor GDC-0941 displays profound in vitro activity and prolonged the life of tumor-bearing animals in an orthotopic xenograft mouse model of most aggressive MYC-amplified human medulloblastoma.